Abstract
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in Wuhan, Hubei, China, and has since spread to more than 200 other countries at the time of writing. In light of this situation, the Japanese Government declared a state of emergency in seven regions of Japan on the April 7, 2020 under the provisions of the law. The medical care delivery system has been under pressure. Although various surgical societies have published guidelines on which to base their surgical decisions, it is not clear how general anesthesia has been performed and will be performed in Japan. Social networks such as Twitter are becoming a part of society, as various information is accumulated on the web. One of the services provided by Twitter is a voting function—Twitter Polls—through which anonymous surveys can be conducted. We analyzed the results of a series of surveys on Twitter on the status of operating restrictions using a mathematical model, and public data provided by the Japanese Government were used to estimate the current and future changes in the number of general anesthesia performed in Japan. The number of general anesthesia was estimated as 1.91*104 cases per week on May 16, 2020, approximately a half reduction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a research grant from the Kansai Medical University (KMU) research consortium to K.H., the branding program as a world-leading research university on intractable immune and allergic diseases from MEXT Japan.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available upon request.
